Controversies& Advancesin the Treatment of Cardiovascular DiseaseThe Twelfth in the Series • September 21 & 22, 2012The Be...
Controversies & Advancesin the Treatment of Cardiovascular DiseaseProgram DescriptionWe are proud to be celebrating the tw...
The Twelfth in the Series • September 21  22, 2012Keynote SpeakersC. Noel Bairey Merz, MD, FACCDr. Bairey Merz holds the W...
FacultyProgram Directors                 Kuang-Yuh Chyu, MD, PhD             Guest Faculty                                ...
Philip J. Ebeling                   Martin B. Leon, MD, FACC               Leslee J. Shaw, PhD, FACCSt. Jude Medical      ...
Preliminary Scientific ProgramSeptember 20, 2012                    DEBATE: Invasive Coronary                CADUCEUS and ...
Keynote Lecture                     CROSSFIRE:                             CROSSFIRE: How ShouldNew Device Regulatory and ...
23RD Annual Meeting Satellite Events  Providing Ongoing Education of Cardiologists and Team Members  Available Courses/Eve...
Registration Information                                        Hotel Accommodations$595 Physician/Industry through August...
Promedica International 2333 State Street, Suite 203                                                                      ...
Upcoming SlideShare
Loading in …5
×

Controversies & Advances in the Treatment of Cardiovascular Disease

737 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
737
On SlideShare
0
From Embeds
0
Number of Embeds
78
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Controversies & Advances in the Treatment of Cardiovascular Disease

  1. 1. Controversies& Advancesin the Treatment of Cardiovascular DiseaseThe Twelfth in the Series • September 21 & 22, 2012The Beverly Hills Hotel – Beverly Hills, CaliforniaProgram Directors: Raj Makkar, MD, FACC,P.K. Shah, MD, FACC, Alfredo Trento, MD, John G. Harold, MD, MACC,Jon Kobashigawa, MD, FACC, Gregory P. Fontana, MD, FACC,William Bommer, MD, FACC 23rd Annual Meeting of the California ACCCo-Sponsored by Promedica International and Cedars-Sinai Medical Center in cooperation with the CaliforniaChapter of the American College of Cardiology, the British Cardiovascular Society, the California Society of ThoracicSurgeons, the American College of Cardiology Foundation, the American Heart Association, and the InternationalAcademy of Cardiology
  2. 2. Controversies & Advancesin the Treatment of Cardiovascular DiseaseProgram DescriptionWe are proud to be celebrating the twelfth annual Controversies and Advances in the Treatmentof Cardiovascular Disease symposium this year! The two-day scientific program will offer realisticviews on many controversial issues in cardiovascular disease today. Session topics will includeimaging, hypertension, stem cells, heart failure, coronary artery disease, transcatheter aortic valvereplacement, mitral valve disease, and cardioembolic stroke.Sessions will include a combination of debates, keynote lectures, crossfires, and roundtablediscussions. A faculty of internationally known leaders in the field has been invited to share theirknowledge and experiences with complex and controversial cases.TARGET AUDIENCEThe conference is designed for cardiologists, cardiovascular and thoracic surgeons, interventionalcardiologists, perfusionists, ICU nurses, technicians and those involved in the diagnosis, treatmentand care of individuals with controversial and complex cases of cardiac disease.Learning ObjectivesUpon completion of this course, participants should be able to:: : Evaluate different imaging modalities and end stage heart disease, including stem cell their treatment implications in the diagnosis therapy, mechanical circulatory support, of cardiovascular diseases. individualized medicine, and the clinical trials: : Understand the benefits and limitations for new therapies. of thiazide diuretics, the Cardiac J Curve, : : Compare and contrast statin safety and and renal denervation in the treatment of efficacy in the treatment of coronary artery hypertension. disease.: : Learn the data from ongoing clinical trials in : : Understand the controversies and debates cell therapy for heart disease, and discuss surrounding transcatheter aortic valve new trials and their potential. replacement.: : Discuss alternatives to the treatment of : : Learn the pathophysiology of mitral end stage heart disease, including organ regurgitation and compare and contrast engineering, xenotransplantation, and medical, interventional, and surgical acquired tolerance for transplant achieved therapies. with bone marrow stem cells. : : Evaluate the debates in stroke prevention for: : Measure the benefits and limitations of atrial fibrillation patients through medical, current approaches to medical therapy for interventional, and surgical treatments.call for AbstractsSubmissions of original abstracts are being accepted and will be considered for oral presentationand poster display when submitted online at www.promedicacme.com.The International Abstract Competition will be held Thursday, September 20, 2012from 6:00 – 8:00 PM.Deadline for Abstract Submissions: August 24, 2012Abstract Categories: : Aortic Stenting : : Congenital Heart Disease : : New Devices: Cardiac: : Aortic Surgery in Adults Resynchronization,: : Arrhythmias : : Congestive Heart Failure Heart Failure Monitors: : Atherosclerosis : : Coronary Surgery : : Percutaneous Valve Repair: : Anti-thrombotic Therapy : : Drug Eluting Stents and Replacement: : Carotid Stenting and : : Healthcare Policy : : Stem Cell Therapy Surgery : : Imaging : : Valvular Heart Disease: : Cell Therapy : : Minimally Invasive Surgery : : Other
  3. 3. The Twelfth in the Series • September 21 22, 2012Keynote SpeakersC. Noel Bairey Merz, MD, FACCDr. Bairey Merz holds the Womens Guild Chair in Womens Health, and is Director of the BarbaraStreisand Heart Center as well as the Preventative and Rehabilitative Cardiac Center at Cedars-SinaiMedical Center. She also is Professor of Medicine at Cedars-Sinai. Dr. Bairey Merzs research interestsinclude women and heart disease, mental stress and heart disease, the role of exercise and stressmanagement in reversing disease, and the role of nutrition in heart disease. Currently, she is chair ofthe National Institutes of Health (NIH)-sponsored WISE (Womens Ischemic Syndrome Evaluation)initiative, which is investigating potential methods for more effective diagnosis and evaluation ofcoronary artery disease in women.Anthony N. DeMaria, MD, MACCDr. DeMaria is the Judith and Jack White Chair in Cardiology and founding director of the SulpizioCardiovascular Center at UCSD. He regularly participates in trials involving non-invasive methods todiagnose and treat heart disease. Dr. DeMaria has received numerous awards and is listed in The BestDoctors in America. He served as a member of the Subspecialty Board on Cardiovascular Disease forthe American Board of Internal Medicine from 1991 to 1997. He is the Editor in Chief of the Journal ofAmerican College of Cardiology and Echocardiography and he serves on the editorial boards and actsas editorial consultant for almost 30 medical journals.David R. Holmes, Jr., MD, MACCDue to his many academic contributions and dedication to cardiovascular care, Dr. Holmes is theimmediate past president of the American College of Cardiology. Over the years, Dr. Holmes has beenrecognized with numerous awards, including the ACC Distinguished Scientist Award (Clinical Domain),has published extensively and serves on the editorial boards of many journals. He is the Edward W.and Betty Knight Scripps Professor in Cardiovascular Medicine at the Mayo Clinic College of Medicinein Rochester, Minnesota.Martin B. Leon, MD, FACCDr. Leon is the Director and CEO of the Cardiovascular Research Foundation and Professor ofMedicine at Columbia University Medical Center as well as the Associate Director of the Center forInterventional Vascular Therapy at CUMC, and a practicing interventional cardiologist at New York-Presbyterian Hospsital. He has served as principal investigator for over 50 clinical trials that havehelped shape the field of interventional cardiovascular medicine, including STRESS, STARS, Gamma1, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial.Michael J. Mack, MD, FACCLong recognized as a thought-leader in the fields of percutaneous valve therapy and minimallyinvasive cardiothoracic surgery, Dr. Mack is the immediate Past President of the Society of ThoracicSurgeons. He also serves as Medical Director of Cardiovascular Surgery for the Baylor HealthcareSystem, is Chairman of the Heart Hospital, Baylor Plano Research Center and is Chairman of theCardiopulmonary Research Science Technology Institute (CRSTI).
  4. 4. FacultyProgram Directors Kuang-Yuh Chyu, MD, PhD Guest Faculty Lawrence S.C. Czer, MD, FACCRaj Makkar, MD, FACC Suhail Y. Dohad, MD, FACC Ezra A. Amsterdam, MD, FACCCedars-Sinai University of California, Davis Neal Eigler, MD, FACCHeart Institute Sacramento, CALos Angeles, CA Fardad Esmailian, MD, FACC Steven F. Bolling, MD, FACCP.K. Shah, MD, FACC James S. Forrester, MD, FACC University of MichiganCedars-Sinai Bruce L. Gewertz, MD Ann Arbor, MIHeart Institute Matthew J. Budoff, MD, FACCLos Angeles, CA Swaminatha Gurudevan, MD, FACC University of California,Alfredo Trento, MD Michele Hamilton, MD, FACC Los AngelesCedars-Sinai Hasan Jilaihawi, MD David GeffenHeart Institute School of Medicine Saibal Kar, MD, FACCLos Angeles, CA Torrance, CA Ronald P. Karlsberg, MD, FACCJohn G. Harold, MD, MACC Vito M. Campese, MDCedars-Sinai Robert M. Kass, MD University of SouthernHeart Institute Ali Khoynezhad, MD, PhD, FACC CaliforniaLos Angeles, CA Keck School of Medicine Asher Kimchi, MD, FACC Los Angeles, CAJon Kobashigawa, MD, FACCCedars-Sinai Michelle Kittleson, MD, PhD, FACC Blase A. Carabello, MD, FACCHeart Institute Norman E. Lepor, MD, FACC Houston Veterans AffairsLos Angeles, CA Medical Center Frank Litvack, MD, FACCWilliam Bommer, MD, FACC Houston, TX Patrick D. Lyden, MDUniversity of California, Davis Anson Cheung, MDSacramento, CA Hooman Madyoon, MD, FACC St. Pauls Hospital Eduardo Marbán, MD, PhD, FACC Vancouver, CanadaHonorary Program James K. Min, MD, FACC W. Randolph Chitwood, Jr., MD, FACC East Carolina University BrodyDirector Jaime D. Moriguchi, MD, FACC School of Medicine Jignesh K. Patel, MD, PhD, FACC Greenville, NCGregory P. Fontana, MD, FACC David J. Cohen, MD, MSc Daniel J. Rader, MDLenox Hill Hospital St. Luke’s Mid AmericaNew York, NY Danny Ramzy, MD, PhD, FACC Heart Institute Bruce A. Samuels, MD, FACC Kansas City, MOLocal Faculty Ernst Schwarz, MD, PhD, FACC Jack G. Copeland III, MD, FACC Michael Shehata, MD, FACC University of California, San DiegoC. Noel Bairey Merz, MD, FACC Takahiro Shiota, MD, FACC San Diego, CADaniel S. Berman, MD, FACC Robert J. Siegel, MD, FACC Keith D. Dawkins, MD, FACCBojan Cercek, MD, PhD, FACC Charles D. Swerdlow, MD, FACC Boston Scientific CorporationWen Cheng, MD Natick, MA Ronald G. Victor, MD, FACCSumeet Chugh, MD, FACC Anthony N. Demaria, MD, MACC University of California, San Diego Medical Center San Diego, CA Marcelo F. Di Carli, MD, FACC Brigham and Womens Hospital Boston, MA
  5. 5. Philip J. Ebeling Martin B. Leon, MD, FACC Leslee J. Shaw, PhD, FACCSt. Jude Medical Columbia University Emory UniversityMaple Grove, MN Medical Center School of MedicineWilliam Fearon, MD, FACC New York, NY Atlanta, GAStanford School of Medicine Joseph R. Leventhal, MD Charles A. Simonton, MD, FACCStanford, CA Northwestern Memorial Hospital Abbott VascularTed Feldman, MD, FACC Chicago, IL Santa Clara, CAEvanston Hospital Michael J. Mack, MD, FACC Gregg W. Stone, MD, FACCEvanston, IL The Heart Hospital Baylor Plano Columbia UniversityGregg C. Fonarow, MD, FACC Plano, TX Cardiac Research FoundationUniversity of California, James B. McClurken, MD, FACC New York, NYLos Angeles Temple University Doris A. Taylor, PhD, FACCDavid Geffen School of Medicine School of Medicine Texas Heart InstituteLos Angeles, CA Philadelphia, PA Houston, TXChip Hance Franz Messerli, MD, FACC Paul S. Teirstein, MD, FACCAbbott Vascular St. Lukes-Roosevelt Hospital Center Scripps ClinicSanta Clara, CA New York, NY La Jolla, CAJoshua M. Hare, MD, FACC Jeffrey W. Moses, MD, FACC Martyn R. Thomas, MDUniversity of Miami Health System Columbia University St. Thomas HospitalMiami, FL Medical Center London, United KingdomRobert C. Hendel, MD, FACC New York, NY John G. Webb, MD, FACCUniversity of Miami David E. Newby, MD, PhD St. Paul’s HospitalSchool of Medicine University of Edinburgh Vancouver, CanadaMiami, FL Edinburgh, United Kingdom Brian K. Whisenant, MD, FACCTimothy D. Henry, MD, FACC Manesh R. Patel, MD, FACC Intermountain Medical CenterMinneapolis Heart Institute Duke University Murray, UTFoundation Durham, NC Larry WoodMinneapolis, MN Jeffrey L. Platt, MD Edwards LifesciencesDavid R. Holmes, Jr., MD, FACC University of Michigan Irvine, CAMayo Clinic Ann Arbor, MI Andreas Zeiher, MDRochester, MN Jeffrey J. Popma, MD, FACC JW Goethe UniversityScott Huennekens Beth Israel Deaconess Frankfurt, GermanyVolcano Corporation Medical Center William A. Zoghbi, MD, FACCSan Diego, CA Boston, MA Methodist DeBakeyDipti Itchhaporia, MD, FACC Subha V. Raman, MD, FACC Heart Vascular CenterNewport Coast Cardiology The Ohio State University Houston, TXNewport Beach, CA Columbus, OHSamir Kapadia, MD, FACC Michael J. Reardon, MD, FACCCleveland Clinic Methodist DeBakeyCleveland, OH Heart Vascular CenterNorman M. Kaplan, MD Houston, TXUT Southwestern Medical Center Rita F. Redberg, MD, MSc, FACCDallas, TX University of California,Jonathon A. Leipsic, MD San Francisco Medical CenterSt. Pauls Hospital San Francisco, CAVancouver, Canada Maurice E. Sarano, MD Mayo Clinic Rochester, MN
  6. 6. Preliminary Scientific ProgramSeptember 20, 2012 DEBATE: Invasive Coronary CADUCEUS and Beyond Angiography and Fractional Eduardo Marbán, MD, PhD, FACC6:00 – 8:00 PM Flow Reserve Should Supplant Ongoing and New Clinical TrialsModerated Oral Abstract Session the Need for Stress Testing in Cell TherapyModerators: Wen Cheng, MD with Imaging Timothy D. Henry, MD, FACCSwaminatha Gurudevan, MD, FACC : : ProDanny Ramzy, MD, PhD, FACC Jeffrey W. Moses, MD, FACC SESSION IV: ALTERNATIVESHooman Madyoon, MD, FACC : : Con TO THE TREATMENT Robert C. Hendel, MD, FACC OF END STAGE HEART DISEASE Moderators:September 21, 2012 DEBATE: A Nuclear Stress Test Jon Kobashigawa, MD, FACCWelcome Address is Warranted for All Patients Michele Hamilton, MD, FACC with a Significantly Elevated Organ EngineeringACC and STS California Coronary Calcium ScoreChapter Update Doris A. Taylor, PhD, FACC : : ProJohn G. Harold, MD, MACC Leslee J. Shaw, PhD, FACC XenotransplantationDipti Itchhaporia, MD, FACC : : Con Jeffrey L. Platt, MDWilliam Bommer, MD, FACC Matthew J. Budoff, MD, FACCJeffrey Milliken, MD Acquired Tolerance with Getting to the Heart with Bone Marrow Stem CellsSESSION I: IMAGING Anti-matter and Organ TransplantModerators: Daniel Berman, MD, FACC David E. Newby, MD, PhD Joseph R. Leventhal, MDJames K. Min, MD, FACC Keynote Lecture Mechanical CirculatoryTreatment Implications of. . . Support Devices Women and Heart DiseaseCardiac CT for Transcatheter Beyond Hype: Hard Facts Jack G. Copeland III, MD, FACCAortic Valve Replacement and Practical SolutionsJonathon A. Leipsic, MD DEBATE: C. Noel Bairey Merz, MD, FACC : : Individualized MedicineCardiac PET for Absolute Jignesh K. Patel, MD, PhD, FACCMyocardial Blood Flow SESSION II: HYPERTENSION : : Clinical Trials forMarcelo F. Di Carli, MD, FACC Moderators: Ronald C. Victor, MD, FACC New Therapies Franz H. Messerli, MD, FACC Gregg C. Fonarow, MD, FACCCoronary CT Angiographyfor Non-invasive Fractional DEBATE: Thiazide Diuretics: Roundtable DiscussionFlow Reserve Friend or Foe?James K. Min, MD, FACC : : Pro Rebuttal Recap Norman M. Kaplan, MDCardiac Magnetic Resonance forIntramyocardial Hemorrhage in : : Con September 22, 2012 Franz H. Messerli, MD, FACCthe Post-MI Setting SESSION V: CORONARYSubha V. Raman, MD, FACC DEBATE: The Cardiac J Curve: ARTERY DISEASE Moderators: Fact or Fiction?DEBATE: Management of : : The Cardiac J Curve James S. Forrester, MD, FACCCAD in the Setting of Multiple Gregg W. Stone, MD, FACC Franz H. Messerli, MD, FACCDiscordant Non- Invasive : : Avoiding the J Curve inFindings: Invasive or Medically DEBATE: Statins in Coronary Treatment of HypertensionBased Approach? in the Elderly Artery Disease: : Invasive Norman M. Kaplan, MD : : Overused? Paul S. Teirstein, MD, FACC : : Counter Argument Rita F. Redberg, MD, MSc, FACC: : Medically Ronald G. Victor, MD, FACC : : Safe and Evidence Abounds Manesh R. Patel, MD, FACC P.K. Shah, MD, FACC DEBATE: Renal Denervation:DEBATE: For the Low-to- Hope or Hype? Multivessel Stable CoronaryIntermediate Risk Patient with : : The Premise Artery Disease: A Broad View ofAcute Chest Pain, Coronary Vito M. Campese, MD the Clinical EvidenceCT Angiography Should be : : The Promise : : An Interventionalist’sthe Standard of Care in the Daniel J. Rader, MD Perspective : : Potential Limitations David R. Holmes, Jr., MD, FACCEmergency Department Ronald G. Victor, MD, FACC : : A Surgeon’s Perspective: : Pro Michael J. Mack, MD, FACC Jeffrey W. Moses, MD, FACC: : Con SESSION III: STEM CELLS SESSION VI: TAVR Ezra A. Amsterdam, MD, FACC Bone Marrow Cell Experience Keynote Lecture and BAMI Transcatheter Aortic Valve Andreas Zeiher, MD Replacement: What A Decade MSCs It Has Been! Joshua M. Hare, MD, FACC Martin B. Leon, MD, FACC
  7. 7. Keynote Lecture CROSSFIRE: CROSSFIRE: How ShouldNew Device Regulatory and Moderate AVR Risk Patients: We Treat Functional MitralReimbursement Challenges Is it OK to be Aggressive Regurgitation?Collaboration is The Key to with TAVR? : : Functional Mitral RegurgitationSuccess: TAVR, A Case in Point : : An Interventionalist’s is a Ventricular Disease and: : An Interventionalist’s Perspective Should be Treated Medically Perspective Martin B. Leon, MD, FACC Blase A. Carabello, MD, FACC David R. Holmes, Jr., MD, FACC : : A Surgeon’s Perspective : : Functional Mitral Regurgitation: : A Surgeon’s Perspective Michael J. Reardon, MD, FACC is a Surgical Disease and Michael J. Mack, MD, FACC : : A Neutral Perspective Should be Treated Surgically Blase A. Carabello, MD. FACC Steven F. Bolling, MD, FACCTAVR – United States : : MitraClip is the Best Debate: Asymptomatic Treatment for FunctionalUnited States Sapien Valve Mitral Regurgitation Aortic StenosisMartin B. Leon, MD, FACC Gregg W. Stone, MD, FACC : : Need to be More AggressiveUnited States CoreValve Blase A. Carabello, MD, FACC DEBATE: DegenerativeJeffrey J. Popma, MD, FACC : : Need to be Appropriately Mitral Regurgitation Conservative?TAVR – International Maurice E. Sarano, MD : : Minimally Invasive Surgery is the Safest and MostNext Generation Valves Effective TreatmentJohn G. Webb, MD, FACC Debate: Balloon vs. Self W. Randolph Chitwood, Jr., MD, FACC ExpandingFacilitating Technology: : : Transcatheter Therapies : : I Prefer the Balloon Will Become The Solution forE- Sheath, Distal Embolic Expandable Most PatientsProtection Samir Kapadia, MD, FACC Ted Feldman, MD, FACCJohn G. Webb, MD, FACC : : Self Expanding Will Become The Gold Standard Surgical Treatment ofRoundtable Discussion Jeffrey J. Popma, MD, FACC Complex Degenerative MitralTAVR: How Important Regurgitationis Alternative Access? Judicious Utilization of TAVR Alfredo Trento, MD Technology: A Balancing ActDirect Aortic, Subclavian Martyn R. Thomas, MD SESSION VIII:Michael J. Reardon, MD, FACC Wrap Up Roundtable CARDIOEMBOLIC STROKETransapical Moderators: Moderators: Saibal Kar, MD, FACCAnson Cheung, MD Gregg W. Stone, MD, FACC Gregory P. Fontana, MD, FACC Raj Makkar, MD, FACCDebate: Do the Options DEBATE: The PFO Chapter Michael J. Mack, MD, FACCof Valve in Valve Change Is Closed; The Device Closure Martin B. Leon, MD, FACCMy Surgical Valve Selection is Unethical Outside ofin Younger and Moderate Keynote Lecture Clinical TrialsRisk Patients? My Dispassionate and : : Pro: : Yes Unbiased Take on TAVR: Patrick Lyden, MD Anson Cheung, MD A Neutral Opinion : : Con: : No Anthony DeMaria, MD, MACC Ted Feldman, MD, FACC Steven F. Bolling, MD, FACC: : Rebuttal CROSSFIRE: Stroke SESSION VII: MITRAL VALVE DISEASE and Atrial FibrillationIs TAVR Worth It? QOL/Financial Moderators: Gregg W. Stone, MD, FACC : : Left Atrial AppendageFeasibility Analysis Saibal Kar, MD, FACC Occlusion is Safest andDavid J. Cohen, MD, MSc at Least as Efficacious as Understanding the Medical TherapyTAVR Controversies Pathophysiology of Mitral Brian K. Whisenant, MD, FACC Regurgitation : : There is InadequateDebate: Stroke Support for the Routine Use William A. Zoghbi, MD, FACC: : Overblown of LAA Occlusion Samir Kapadia, MD, FACC Rita F. Redberg, MD, MSc, FACC DEBATE: Asymptomatic Severe: : A Real and Continued Problem : : Surgical MAZE Procedure Martyn R. Thomas, MD Mitral Regurgitation Should Be and Appendage Exclusion Treated Conservatively Provides the Most PracticalDebate: Paravalvular Leak: : : Pro Solution for Atrial FibrillationHow Big of a Deal is It? Robert J. Siegel, MD, FACC W. Randolph Chitwood, Jr., MD, FACC: : The Problem : : Con Michael J. Mack, MD, FACC Maurice E. Sarano, MD: : Potential Solutions John G. Webb, MD, FACC September 21 22, 2012
  8. 8. 23RD Annual Meeting Satellite Events Providing Ongoing Education of Cardiologists and Team Members Available Courses/Events: Í Controversies” Celebration CA ACC “ Awards DinnerÍ 3rd Annual Advances in the Treatment Saturday September 22, 2012 of Heart Failure Symposium 6:30 – 9:30 PM • Sunset Foyer/Ballroom Thursday, September 20, 2012 CA ACC Members /Guests – The Westin South Coast Plaza Complimentary/$40. Controversies 686 Anton Boulevard Attendees just $75. Advance Reservations Costa Mesa, CA 92626 REQUIRED. Come enjoy a memorable night 1:45 PM Registration featuring camaraderie, décor, delectable 2:00 – 6:00 PM Presentations dinner, and and world-class entertainment 6:00 – 7:00 PM Reception by Armando Compean and Texas Brown – *Keynote presentation given by ACC a gift from CA ACC to those that care for President, William Zoghbi, MD, FACC our patients. Course Directors: Please contact the CA ACC Chapter directly at Dipti Itchhaporia, MD, FACC, 1-877-460-5880 or at administrator@caacc.org and Pravin M. Shah, MD, MACC to make your reservation. Registration: 800-514-4624 or online at www.Hoag.org/ATHF Other CA ACC Events : (by invitation only or your special request) All Following Events To Be Held at The Beverly Hills Hotel, Í CA ACC Board of Directors/Council/ Beverly Hills Committee Meeting Sunday September 23, 2012Í ardiac Care Associates Educational C 8:30 AM – 2:00 PM • Sunset Ballroom Session Networking Reception Elected/Appointed Leaders Friday September 21, 2012 Breakfast, Meetings, Lunch. Addressing 5:00 – 8:30 PM • Polo Private Room all of the hot topics facing Cardiology in Please contact the CA ACC Chapter directly at California today. 1-877-460-5880 or at administrator@caacc.org to make your reservation. California Chapter of the American Proud Partner of the College of Cardiology mission: To advocate for accessible, highest quality, cost effective cardiovascular care for Californians.
  9. 9. Registration Information Hotel Accommodations$595 Physician/Industry through August 17, 2012 A special room rate of $405 per night plus tax at$695 Physician/Industry after August 17, 2012 the celebrated Beverly Hills Hotel has been arranged$395 Nurse/Resident/Technician through for program participants. Reserve your room prior to August 17, 2012 the cutoff date of Thursday, August 30, 2012 by calling$495 Nurse/Resident/Technician after 1-800-283-8885, or 1-310-276-2251. Mention your August 17, 2012 affiliation with the Controversies and Advances in the$395 ACC National Members Treatment of Cardiovascular Disease symposium to receive the special rate.$195 California Chapter ACC Members/ Cardiac Care Associates CME Accreditation and DesignationRegistration fees include breaks, lunches, and welcome Promedica International is accredited byreception, as well as scientific program materials. Please the Accreditation Council for Continuingmake checks payable to Promedica International in U.S. Medical Education to provide continuingdollars drawn on a U.S. bank. Visa, MasterCard, Discover medical education for physicians.and American Express credit cards are also accepted. Promedica International designates this live activityRegistrations should be faxed, mailed or submitted for a maximum of 19 AMA PRA Category 1 Credit(s)™.online at www.promedicacme.com. Physicians should claim only the credit commensurate with the extent of their participation in the activity.To register, please complete the attached form and mailor fax to: Provider approved by the California Board of Registered Nursing, Provider #8495 for 19 Contact Hours.Promedica International2333 State Street, Suite 203, Carlsbad, CA 92008 Category 1 CEUs for Perfusionists have been appliedTel: (760) 720-2263, Fax: (760) 720-6263 for through the American Board of CardiovascularLsteigerwald@promedicacme.com Perfusion (ABCP).Refunds Activity EvaluationAll cancellations must be submitted in writing, via Evaluation by online questionnaire will addressfacsimile or postal mail. Refunds are subject to a content, presentation, and future educational needs.$100 administration charge. Cancellations cannotbe accepted over the telephone. Refunds will not beavailable after August 17, 2012.Controversies Advancesin the Treatment of Cardiovascular DiseaseSeptember 21 22, 2012 • The Beverly Hills Hotel - Beverly Hills, CaliforniaVisit us at www.promedicacme.com for convenient online registration. Physician/Industry: Nurse/Resident/Technician: ACC National Members: $395 $595 through August 17, 2012 $395 through August 17, 2012 California Chapter ACC Members/$695 after August 17, 2012 $495 after August 17, 2012 Cardiac Care Associates: $195All fees in US dollars drawn on US banks:P  Check Enclosed P Visa/MasterCard     P  American Express P DiscoverCredit Card Number Expiration DateSignatureFirst/Last Name P MD   PRN  PCCP  PNPInstitutionMailing AddressCity/State/Zip/CountryTelephone FaxEmail Address SpecialtyPlease mail or fax to: Promedica International, 2333 State Street, Suite 203, Carlsbad, CA 92008 Tel: (760) 720-2263, Fax: (760) 720-6263, Lsteigerwald@promedicacme.com
  10. 10. Promedica International 2333 State Street, Suite 203 Presort Standard Carlsbad, CA 92008 U.S. Postage Paid Permit 1948 San Diego CAControversies Advancesin the Treatment of Cardiovascular DiseaseThe Twelfth in the Series • September 21 22, 2012The Beverly Hills Hotel – Beverly Hills, California 23RD Annual Meeting of the California ACC What They’re Saying: : : An outstanding program on cutting-edge subjects presented in a manner that invites active participation. A : : well-deserved reputation for a high-quality program! E : : xcellent program that brings cardiology and cardiac surgery together. T : : he presentations were informative and entertaining. One of the best meetings I’ve attended! E : : xceptional faculty, timely topics, extremely well organized. C : : onsistently great conference, year after year! A : : s always, the “Controversies” committee presented the latest and greatest in cardiovascular research and treatment in a provocative and innovative format.

×